Name: ABSCI CORP (ABSI) Stock
Brand: ABSCI CORP
Rating: 6.5 (3 reviews)

ABSI Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Absci Corporation

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

2 days ago - By: Absci Corporation

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

3 days ago - By: Absci Corporation

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

3 days ago - By: Absci Corporation

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

8 days ago - By: Zacks Investment Research - Mentions: ANIP CRMD ARQT

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study

9 days ago - By: Absci Corporation

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

9 days ago - By: The Motley Fool - Mentions: SOUN PLTR UPST RXRX ...

10 AI Stocks Worth Buying Right Now

a month ago - By: Benzinga - Mentions: ZYXI MRSN CMND OTLK ...

12 Health Care Stocks Moving In Thursday's Intraday Session

a month ago - By: The Motley Fool

Absci (ABSI) Q3 2025 Earnings Call Transcript

a month ago - By: Benzinga - Mentions: SNDK EGAN KLC KDK ...

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

a month ago - By: Zacks Investment Research - Mentions: BHST

Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates

a month ago - By: Absci Corporation

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

a month ago - By: Absci Corporation

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

a month ago - By: Zacks Investment Research - Mentions: QURE

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates

a month ago - By: Absci Corporation

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

a month ago - By: Absci Corporation

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

2 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

2 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

2 months ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

2 months ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

3 months ago - By: Absci Corporation; Oracle; AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

3 months ago - By: Absci Corporation; Oracle; AMD - Mentions: AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

4 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

4 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

4 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

4 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

4 months ago - By: Zacks Investment Research - Mentions: CLNN

ABSCI CORP (ABSI) Stock News

ABSI Latest News, Press Relases and Analysis

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

10 AI Stocks Worth Buying Right Now

12 Health Care Stocks Moving In Thursday's Intraday Session

Absci (ABSI) Q3 2025 Earnings Call Transcript

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates